Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Tumor necrosis factor (TNF) plays an important role in host defense and tumor growth
control. Therefore, anti-TNF antibody therapies may increase the risk of serious infections
and malignancies.